Balanced news tone
News Sentiment
FMS sentiment intelligence
Fresenius Medical Care Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
85/100 classification confidence.
directly relevant articles
high-authority source matches
+2.1% over one week, +4.3% over four weeks, trend active, and near fair-value range.
FMC stock steadies as Fresenius Medical Care keeps its U.S. listing
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
FMC stock steadies as Fresenius Medical Care keeps its U.S. listing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 12:06
- Source
- Ad Hoc News
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Given Average Rating of "Reduce" by Brokerages
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 12 Jul 2026 18:45
- Source
- MarketBeat
Fresenius Medical: High Yield, Utilities-Like Stock At Valuation Lows
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jul 2026 09:28
- Source
- Seeking Alpha
FMS stock steadies as Fresenius Medical Care keeps its core business in view
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 14:54
- Source
- Ad Hoc News
Fresenius Medical Care stock stays supported by dialysis demand and restructuring progress
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 09 Jul 2026 18:40
- Source
- Ad Hoc News
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 18:04
- Source
- TradingView
FRESENIUS MEDICAL CARE-ADR (FMS) Stock Chart
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 10:24
- Source
- ChartMill
Moran Wealth Management LLC Has $7.85 Million Holdings in Fresenius Medical Care AG & Co. KGaA $FMS
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jul 2026 07:00
- Source
- MarketBeat
How Investors Are Reacting To Fresenius Medical Care (XTRA:FME) Losing EU Backing For TAVNEOS®
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- simplywall.st
FMC Fresenius Medical Care, background on dialysis business and stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 18:20
- Source
- Ad Hoc News
ETFs Investing in Fresenius Medical Care AG Sponsored ADR Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 17:58
- Source
- TradingView
Fresenius Medical Care (XTRA:FME) Faces EU Setback After TAVNEOS Revocation Recommendation
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 02:06
- Source
- Simply Wall St.
Fresenius Medical Care Friday sector check, dialysis stock in focus for health investors
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 18:54
- Source
- Ad Hoc News
Fresenius Medical Care dips after US proposes lower dialysis reimbursement rate
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Investing.com
Fresenius Medical Care AG (FMS) Stock Analysis: Is a 25.82% Upside on the Horizon for This Healthcare Giant?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- DirectorsTalk Interviews
Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- Finansavisen
Read This Before Considering Fresenius Medical Care AG (ETR:FME) For Its Upcoming €1.49 Dividend
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 17 May 2026 07:00
- Source
- simplywall.st
Fresenius Medical Care's (ETR:FME) Earnings Offer More Than Meets The Eye
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- simplywall.st
DaVita Continues to Outperform Key Peer Fresenius Medical Care
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 06 May 2026 07:00
- Source
- Morningstar
Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- PR Newswire
Fresenius Medical: The Undervaluation Is Getting Clearer (NYSE:FMS)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Seeking Alpha
Fresenius Medical Care AG (FMS) Stock Falls on Q1 2026 Earnings
- Tone
- Negative 22/100
- Event
- Earnings
- Published
- 05 May 2026 07:00
- Source
- Quiver Quantitative
Fresenius Medical Care Shares Fall After Decline in U.S. Treatment Volumes
- Tone
- Negative 6/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- WSJ
Humacyte (HUMA) takes ex-U.S. Symvess control as Fresenius retains 8.4% stake
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 27 Apr 2026 07:00
- Source
- Stock Titan
Fresenius Medical Care AG (FMS) Looks to Improve Profitability After Smashing Q4 Expectations
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Mar 2026 07:00
- Source
- Market source
Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 24 Feb 2026 08:00
- Source
- Fresenius Medical Care
Fresenius Medical Care (FMS) Stock Price Today & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Feb 2026 20:30
- Source
- Gotrade
Fresenius Medical Care: Low Confidence On Growth Acceleration Limits Upside (NYSE:FMS)
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 29 Jan 2026 08:00
- Source
- Seeking Alpha
3 Undervalued Medical Instrument Stocks Poised to Grow in 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jan 2026 08:00
- Source
- TradingView
Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 04 Nov 2025 08:00
- Source
- Fresenius Medical Care